Related Experiment Video
Updated: Jun 22, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Silent infarcts in young children with sickle cell disease
Janet L Kwiatkowski1, Robert A Zimmerman, Avrum N Pollock
1Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. kwiatkowski@email.chop.edu
Insights
Silent infarcts are common in young children with sickle cell disease (SCD-SS), affecting over 27% of asymptomatic individuals under six. Early detection is crucial as silent infarcts are linked to potential neurocognitive deficits.
Area of Science:
- Pediatric Neurology
- Hematology
- Radiology
Background:
- Silent infarcts are prevalent in school-aged children with sickle cell disease (SCD-SS) and linked to neurocognitive deficits.
- The occurrence of silent infarcts in younger children with SCD-SS remains underdefined.
Purpose of the Study:
- To determine the prevalence of silent infarcts in children with SCD-SS before the age of six.
- To identify clinical and laboratory factors associated with silent infarcts in this pediatric cohort.
Main Methods:
- Retrospective analysis of brain MRI/A studies in children with SCD-SS under six years old.
- Calculation of silent infarct prevalence in asymptomatic children.
- Comparison of clinical and laboratory parameters between children with and without silent infarcts.
Main Results:
- 18 out of 65 neurologically asymptomatic children (27.7%) had silent infarcts, with a mean age of 3.7 years.
- Silent infarcts were associated with cerebral vessel stenosis, lower rates of vaso-occlusive pain and acute chest syndrome, and lower hemoglobin levels.
- Prevalence in young children mirrors that in older children.
Conclusions:
- Silent infarcts are a significant finding in young children with SCD-SS, similar in prevalence to older children.
- Anemia and severe vasculopathy may be identified as risk factors for silent infarcts in children with SCD-SS.
Abstract:
Silent infarcts have been reported most commonly in school-aged children with homozygous sickle cell disease (SCD-SS) and are associated with neurocognitive deficits. However, the prevalence of silent infarcts in younger children with SCD-SS is not well defined. In this retrospective study, brain magnetic resonance imaging and angiography (MRI/A) studies performed before 6 years of age in a cohort of children with SCD-SS were analysed and the prevalence of abnormalities was calculated. Clinical and laboratory parameters were compared between the groups with and without silent infarcts. Sixty-eight of 96 children in the cohort had brain MRI/A performed prior to age 6 years. Of the 65 who were neurologically asymptomatic, 18 (27.7%, 95% CI 17.3-40.2%) had silent infarcts (mean age 3.7 +/- 1.1 years, range 1.3-5.9 years). Factors associated with silent infarcts included cerebral vessel stensosis by magnetic resonance angiography, lower rates of vaso-occlusive pain and acute chest syndrome and lower haemoglobin levels. The prevalence of silent infarcts in young children with SCD-SS is similar to that of older children and anaemia and severe vasculopathy may be risk factors.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Ischemic Stroke l: Introduction
